Negative Effect of Intravenous Antibiotics on Survival in Patients with Triple-Negative Breast Cancer
In summary, IABs during adjuvant chemotherapy seems to be a risk factor for inferior OS, BCSS, and DDFS in TNBC patients, possibly by affecting microbiome-related immune response modulation. Hence, preventive measures to avoid the need for IABs should be considered in these patients.
Authors
- Davut Dayan (ORCID: https://orcid.org/0000-0003-1589-2016)
- Brigitte Rack (ORCID: https://orcid.org/0000-0002-7539-4839)
- Elena Leinert (ORCID: https://orcid.org/0000-0001-5795-3417)
- Sabine Heublein (ORCID: https://orcid.org/0000-0002-5326-0186)
- Thomas W. P. Friedl (ORCID: https://orcid.org/0000-0002-4773-8067)
- Wolfgang Janni (ORCID: https://orcid.org/0000-0001-5911-2400)
- Stefan Lukac (ORCID: https://orcid.org/0000-0002-9336-2267)
- Kristina Veselinovic
- Krisztián Látó (ORCID: https://orcid.org/0000-0001-7592-8055)
- Visnja Fink
Institutions
- University Hospital Ulm (DE)
Publication Details
- Journal
- Cancers
- Published
- 2025-04-29
- DOI
- https://doi.org/10.3390/cancers17091498
- Citations
- 2
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- Heinrich-Heine-Universität Düsseldorf